Stay updated on Pembrolizumab & Lanreotide for GI NETs Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Lanreotide for GI NETs Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Lanreotide for GI NETs Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page now displays a new revision tag (Revision: v3.5.5) replacing the previous v3.5.4. This reflects a software or template update rather than changes to study data.
    Difference
    0.1%
    Check dated 2026-06-05T16:13:30.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.3 to v3.5.4, indicating a minor update to the page's documentation.
    Difference
    0.1%
    Check dated 2026-05-15T05:50:06.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page’s displayed revision number was updated from v3.5.2 to v3.5.3, indicating a minor platform/release change without altering the study record.
    Difference
    0.1%
    Check dated 2026-04-24T06:37:23.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:49:09.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Site revision history shows an addition of v3.5.0 and deletion of v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T08:53:12.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.1%
    Check dated 2026-03-12T04:29:36.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Lanreotide for GI NETs Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Lanreotide for GI NETs Clinical Trial page.